MB "SSPharmacy" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
40,000 |
- |
39,993 |
39,993 |
- |
100.00 |
99.98 |
39,993 |
0 |
0 |
39,993 |
2024 |
---|
299,307 |
- |
234,438 |
222,700 |
- |
99.98 |
74.41 |
222,700 |
21,261 |
36,123 |
207,838 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
299,307 €648 % *
Sales per employee (€)
-Profit before tax (€)
234,438 €486 % *
Net Profit (€)
222,700 €457 % *
Profit per employee (€)
-Total profitability (%)
99.98 %-0.02 % *
Net profitability (%)
74.41 %-25.58 % *
Equity (€)
222,700 €457 % *
Amounts Payable And Liabilities (€)
21,261 €- *
Non-current Assets (€)
36,123 €- *
CurrentAssets (€)
207,838 €420 % *